Provention Bio: Sanofi - Aventis Groupe: Press Release: Sanofi completes acquisition of Provention Bio, Inc.
Sanofi completes acquisition of Provention Bio, Inc. Paris, April 27 2023. Sanofi announced today the completion of its acquisit (https://www.sanofi.com/en/media-room/press-releases/2023/2023-03-13...
Read full article »
Provention Bio is a New Jersey-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of autoimmune diseases.
Read more